Bank of America Downgrades Seattle Genetics To Underperform By: Benzinga via Benzinga September 30, 2014 at 08:38 AM EDT Analysts at Bank of America downgraded Seattle Genetics (NASDAQ: SGEN) from Neutral to Underperform. The target price for Seattle ... Read More >> Related Stocks: Seagen Inc